SCHEMBL26645373

SCHEMBL26645373

CC1Cn2nc(Br)c(I)c2CN1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26645043 1.00 — —
SCHEMBL26645369 1.00 — —
SCHEMBL26645349 0.82 SETD7 (0.34) —
SCHEMBL26645470 0.76 SMO (0.40) —
SCHEMBL26645595 0.76 SMO (0.34) —
SCHEMBL26645067 0.76 SMO (0.40) —
SCHEMBL26645666 0.76 SMO (0.34) —
SCHEMBL26645225 0.76 SMO (0.40) —
SCHEMBL26645657 0.76 SMO (0.40) —
SCHEMBL16701069 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback